Listed

Nephros Inc: Form 10-Q for the period ended Sep 30, 2012

Filed with the SEC on Nov 9, 2012 and accepted by EDGAR at Nov 9, 2012, 10:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-07-01 to 2012-09-30$604.0kus-gaap:SalesRevenueNet
Revenue9 months2012-01-01 to 2012-09-30$1.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2012-07-01 to 2012-09-30$191.0kus-gaap:CostOfGoodsSold
Cost of revenue9 months2012-01-01 to 2012-09-30$448.0kus-gaap:CostOfGoodsSold
Gross profit3 months2012-07-01 to 2012-09-30$413.0kus-gaap:GrossProfit
Gross profit9 months2012-01-01 to 2012-09-30$991.0kus-gaap:GrossProfit
Selling, general and administrative3 months2012-07-01 to 2012-09-30$1.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2012-01-01 to 2012-09-30$2.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2012-07-01 to 2012-09-30−$853.0kus-gaap:OperatingIncomeLoss
Operating income9 months2012-01-01 to 2012-09-30−$2.2mus-gaap:OperatingIncomeLoss
Net income3 months2012-07-01 to 2012-09-30−$853.0kus-gaap:NetIncomeLoss
Net income9 months2012-01-01 to 2012-09-30−$2.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2012-07-01 to 2012-09-30−$0.07us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2012-01-01 to 2012-09-30−$0.20us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2012-01-01 to 2012-09-30−$1.1mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2012-01-01 to 2012-09-30$7.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-09-30$366.0kus-gaap:Cash
Current assetsAt period end2012-09-30$1.8mus-gaap:AssetsCurrent
Total assetsAt period end2012-09-30$4.0mus-gaap:Assets
Current liabilitiesAt period end2012-09-30$2.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-09-30$3.6mus-gaap:Liabilities
Shareholders' equityAt period end2012-09-30$323.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-060660. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.